» Articles » PMID: 32443324

Trihexyphenidyl Induced Malignant Hyperthermia in a Patient with Parkinson's Disease Complicated with Pneumonia: A Case Report

Overview
Specialty General Medicine
Date 2020 May 24
PMID 32443324
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Drug-induced fever is easy to overlook in respiratory departments. High fever is a rare side effect of trihexyphenidyl, which can be used clinically to treat Parkinson's disease. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a group of clinical syndromes caused by various diseases, resulting in water retention and refractory hyponatremia. However, pneumonia combined with malignant hyperthermia and SIADH has rarely been reported. We describe an unusual case of malignant hyperthermia and refractory hyponatremia due to trihexyphenidyl adverse reaction.

Patient Concerns: Fifty-five-year-old male with pneumonia presented with malignant hyperthermia and refractory hyponatremia has a history of Parkinson's disease.

Diagnosis: Early considerations related the described hyperthermia findings to the manifestations of pneumonia. However, the last findings were due to trihexyphenidyl adverse reaction.

Interventions: Broad-spectrum antibiotics, oral and intravenous supplement of concentrated sodium chloride, drug, and physical cooling.

Outcomes: The patient survived. During the 3-month follow up, the patient was no recurrence of fever or hyponatremia.

Conclusion: High fever and SIADH can be a rare adverse reaction to trihexyphenidyl. Therefore, possible drug factors should be considered in the case. Consideration of other possible causes can improve early diagnosis and treatment of patients with fever of unknown origins.

Citing Articles

The function of previously unappreciated exerkines secreted by muscle in regulation of neurodegenerative diseases.

Bian X, Wang Q, Wang Y, Lou S Front Mol Neurosci. 2024; 16:1305208.

PMID: 38249295 PMC: 10796786. DOI: 10.3389/fnmol.2023.1305208.


Non-antipsychotic medicines and modified electroconvulsive therapy are risk factors for hospital-acquired pneumonia in schizophrenia patients.

Yang Y, Kong D, Li Q, Chen W, Zhao G, Tan X Front Psychiatry. 2023; 13:1071079.

PMID: 36713903 PMC: 9880231. DOI: 10.3389/fpsyt.2022.1071079.

References
1.
Andreassen M, Pedersen S . [Malignant neuroleptic syndrome. A review of epidemiology, risk factors, diagnosis, differential diagnosis and pathogenesis of MNS]. Ugeskr Laeger. 2000; 162(10):1366-70. View

2.
. A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. 1957. J Am Soc Nephrol. 2001; 12(12):2860-2870. DOI: 10.1681/ASN.V12122860. View

3.
Jabbari B, Scherokman B, GUNDERSON C, ROSENBERG M, Miller J . Treatment of movement disorders with trihexyphenidyl. Mov Disord. 1989; 4(3):202-12. DOI: 10.1002/mds.870040302. View

4.
Caroff S, Mann S . Neuroleptic malignant syndrome. Med Clin North Am. 1993; 77(1):185-202. DOI: 10.1016/s0025-7125(16)30278-4. View

5.
Durack D, Street A . Fever of unknown origin--reexamined and redefined. Curr Clin Top Infect Dis. 1991; 11:35-51. View